BR112012017463A2 - constructos de tecido de bioengenharia e métodos para sua produção e uso - Google Patents
constructos de tecido de bioengenharia e métodos para sua produção e usoInfo
- Publication number
- BR112012017463A2 BR112012017463A2 BR112012017463A BR112012017463A BR112012017463A2 BR 112012017463 A2 BR112012017463 A2 BR 112012017463A2 BR 112012017463 A BR112012017463 A BR 112012017463A BR 112012017463 A BR112012017463 A BR 112012017463A BR 112012017463 A2 BR112012017463 A2 BR 112012017463A2
- Authority
- BR
- Brazil
- Prior art keywords
- production
- methods
- bioengineered
- extracellular matrix
- constructs
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
- A61L27/3633—Extracellular matrix [ECM]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
- A61L27/3834—Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3886—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells comprising two or more cell types
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3886—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells comprising two or more cell types
- A61L27/3891—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells comprising two or more cell types as distinct cell layers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0656—Adult fibroblasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0665—Blood-borne mesenchymal stem cells, e.g. from umbilical cord blood
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0668—Mesenchymal stem cells from other natural sources
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/20—Transition metals
- C12N2500/24—Iron; Fe chelators; Transferrin
- C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/02—Compounds of the arachidonic acid pathway, e.g. prostaglandins, leukotrienes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/148—Transforming growth factor alpha [TGF-a]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/39—Steroid hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Developmental Biology & Embryology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Physical Education & Sports Medicine (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
constructos de tecido de bioengenharia e métodos para sua produção e uso a presente invenção se refere a constructos de bioengenharia que são formados a partir de células cultivadas induzidas para sintetizar e secretar componentes da matriz extracelular endogenamente produzida sem o requisito de componentes da matriz exógena ou suporte de rede ou membros de estrutura. os constructos de bioengenharia da invenção podem ser produzidos com múltiplos tipos de célula que podem todos contribuir para produzir a matriz extracelular. adicionalmente ou alternativamente, um dos múltiplos tipos de células pode ser distribuído em um local no corpo através dos componentes da matriz extracelular endogenamente produzida para alcançar vários benefícios terapêuticos.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29507310P | 2010-01-14 | 2010-01-14 | |
US33793810P | 2010-02-12 | 2010-02-12 | |
US34772510P | 2010-05-24 | 2010-05-24 | |
PCT/US2011/021362 WO2011088365A1 (en) | 2010-01-14 | 2011-01-14 | Bioengineered tissue constructs and methods for producing and using thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112012017463A2 true BR112012017463A2 (pt) | 2015-09-15 |
Family
ID=43881131
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112012017463A BR112012017463A2 (pt) | 2010-01-14 | 2011-01-14 | constructos de tecido de bioengenharia e métodos para sua produção e uso |
Country Status (12)
Country | Link |
---|---|
US (1) | US20110293667A1 (pt) |
EP (1) | EP2524034A1 (pt) |
JP (3) | JP2013517292A (pt) |
CN (2) | CN107802890A (pt) |
AU (1) | AU2011205674A1 (pt) |
BR (1) | BR112012017463A2 (pt) |
CA (1) | CA2787050A1 (pt) |
IL (1) | IL220903A0 (pt) |
MX (1) | MX354068B (pt) |
RU (1) | RU2645473C2 (pt) |
SG (1) | SG182508A1 (pt) |
WO (1) | WO2011088365A1 (pt) |
Families Citing this family (73)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8986377B2 (en) | 2009-07-21 | 2015-03-24 | Lifecell Corporation | Graft materials for surgical breast procedures |
US9492952B2 (en) | 2010-08-30 | 2016-11-15 | Endo-Surgery, Inc. | Super-hydrophilic structures |
US20120143228A1 (en) | 2010-08-30 | 2012-06-07 | Agency For Science Technology And Research | Adhesive structure with stiff protrusions on adhesive surface |
EP3851131A1 (en) * | 2011-05-31 | 2021-07-21 | LifeCell Corporation | Adipose tissue matrices |
EP2753247A4 (en) * | 2011-09-06 | 2015-07-08 | Stem Cell Surgical Llc | SURGICAL SUTURES AND METHODS OF MAKING AND USING SUTURES |
AU2012335746B2 (en) | 2011-11-08 | 2017-04-27 | Auxocell Laboratories, Inc. | Systems and methods for processing cells |
BR112014016029B1 (pt) * | 2011-12-29 | 2020-05-19 | Agency Science Tech & Res | estrutura adesiva e processo para produzir uma estrutura adesiva |
US9549812B2 (en) | 2012-01-13 | 2017-01-24 | Lifecell Corporation | Breast prostheses, methods of manufacturing breast prostheses, and methods of treatment using breast prostheses |
CN102599991A (zh) * | 2012-03-20 | 2012-07-25 | 中山大学中山眼科中心 | 美容性角膜镜片的应用 |
US8926881B2 (en) | 2012-04-06 | 2015-01-06 | DePuy Synthes Products, LLC | Super-hydrophobic hierarchical structures, method of forming them and medical devices incorporating them |
US8969648B2 (en) | 2012-04-06 | 2015-03-03 | Ethicon, Inc. | Blood clotting substrate and medical device |
EP3281607B1 (en) * | 2012-06-21 | 2019-03-06 | LifeCell Corporation | Implantable prosthesis having acellular tissue attachments |
US9498559B2 (en) * | 2012-10-08 | 2016-11-22 | Cormatrix Cardiovascular, Inc. | Reinforced vascular protheses |
KR102101689B1 (ko) | 2013-02-08 | 2020-04-17 | 아셀, 인크. | 세포외 기질 재료로부터의 생리활성 겔의 제조 방법 |
KR102252223B1 (ko) | 2013-02-12 | 2021-05-14 | 리플리셀 라이프 사이언시스 인크. | 힘줄 치료 및 회복을 위한 조성물 및 방법 |
EP2956184B9 (en) * | 2013-02-14 | 2018-04-25 | Council of Scientific and Industrial Research | Silk based porous scaffold and a process for the preparation thereof |
EP3027235A1 (en) | 2013-07-30 | 2016-06-08 | Musculoskeletal Transplant Foundation | Acellular soft tissue-derived matrices and methods for preparing same |
WO2015022670A1 (en) * | 2013-08-14 | 2015-02-19 | Stempeutics Research Pvt. Ltd. | Management of osteoarthritis using pooled allogeneic mesenchymal stem cells |
WO2015046216A1 (ja) * | 2013-09-25 | 2015-04-02 | 富士フイルム株式会社 | 生体親和性高分子多孔質体の製造方法、生体親和性高分子多孔質体、生体親和性高分子ブロック並びに細胞構造体 |
US10959839B2 (en) * | 2013-10-08 | 2021-03-30 | Edwards Lifesciences Corporation | Method for directing cellular migration patterns on a biological tissue |
GB201317889D0 (en) | 2013-10-09 | 2013-11-20 | Reneuron Ltd | Product and use |
CL2013003066A1 (es) * | 2013-10-22 | 2014-07-25 | Univ Chile | Composicion para tratamiento de heridas porque comprende matriz soporte y células troncalesmesenquiámicas de gelatina de wharton; metodo para tratar heridas que comprende aplicar dicha composicion |
RU2559921C2 (ru) * | 2013-11-01 | 2015-08-20 | Игорь Иванович Агапов | Способ восстановления целостности тонкой кишки |
CN104726398A (zh) * | 2013-12-20 | 2015-06-24 | 江阴司特易生物技术有限公司 | 固定化的全人源ecm包被基质的制备方法 |
US10500233B2 (en) | 2014-02-12 | 2019-12-10 | Replicel Life Sciences Inc. | Compositions and methods for treating bone, joints and cartilage |
PL3142586T3 (pl) | 2014-05-14 | 2021-05-31 | President And Fellows Of Harvard College | Urządzenie cewnika do przesyłania i odbijania światła |
US9993748B2 (en) | 2014-08-11 | 2018-06-12 | Auxocell Laboratories, Inc. | Centrifuge clip and method |
USD748462S1 (en) | 2014-08-11 | 2016-02-02 | Auxocell Laboratories, Inc. | Centrifuge clip |
WO2016143746A1 (ja) * | 2015-03-12 | 2016-09-15 | 一般財団法人化学及血清療法研究所 | 脱細胞化組織を用いた癒着防止材及び代用生体膜 |
CN104800891B (zh) * | 2015-05-20 | 2017-03-29 | 苏州大学附属第一医院 | 一种增强体外培养间充质干细胞生物抗氧化功能的细胞外基质生物材料、制备方法及其应用 |
CN105769381B (zh) * | 2015-05-26 | 2018-04-17 | 南通大学 | 一种用于组织损伤修复的生物补片 |
CN104958319A (zh) * | 2015-06-01 | 2015-10-07 | 成都清科生物科技有限公司 | 具有卵巢早衰及围绝经期综合征治疗作用的间充质干细胞及其细胞因子制剂及其制备方法 |
WO2017003877A1 (en) * | 2015-06-30 | 2017-01-05 | Lattice Biologics Inc. | Modified extracellular matrix for enhanced stem cell homing and engraftment |
US10912864B2 (en) | 2015-07-24 | 2021-02-09 | Musculoskeletal Transplant Foundation | Acellular soft tissue-derived matrices and methods for preparing same |
US11052175B2 (en) | 2015-08-19 | 2021-07-06 | Musculoskeletal Transplant Foundation | Cartilage-derived implants and methods of making and using same |
EP3337427A1 (en) | 2015-08-21 | 2018-06-27 | Lifecell Corporation | Breast treatment device |
WO2017059089A1 (en) * | 2015-09-29 | 2017-04-06 | Anicell Biotech, Llc | Methods and articles of manufacture for the treatment of animals |
CN105535946A (zh) * | 2015-12-14 | 2016-05-04 | 北京大学第一医院 | 转谷氨酰胺酶在加强角膜力学性质中的应用及生物制剂 |
US20200299649A1 (en) * | 2016-03-29 | 2020-09-24 | Smsbiotech, Inc. | Compositions and methods for using small mobile stem cells |
EP3436566A1 (en) * | 2016-03-30 | 2019-02-06 | Stembiosys, Inc. | Bone marrow stromal cell derived extracellular matrix protein extract and uses thereof |
US11045579B2 (en) | 2016-08-31 | 2021-06-29 | Lifecell Corporation | Breast treatment device |
WO2018071967A1 (en) * | 2016-10-20 | 2018-04-26 | Australian Foundation for Diabetes Research | Cell associated scaffolds for delivery of agents |
CN106563161A (zh) * | 2016-11-08 | 2017-04-19 | 华南生物医药研究院 | 可用于美容的新型药物组合剂 |
CN106619721A (zh) * | 2016-11-08 | 2017-05-10 | 中国人民解放军军事医学科学院野战输血研究所 | 一种增强细胞活性的新方法 |
CN106581760A (zh) * | 2016-11-08 | 2017-04-26 | 华南生物医药研究院 | 增强细胞活性的特殊处理方法 |
JP7165326B2 (ja) * | 2016-12-28 | 2022-11-04 | 株式会社高研 | 高強度コラーゲンスポンジ |
US10368991B2 (en) * | 2017-02-06 | 2019-08-06 | C. R. Bard, Inc. | Device and associated percutaneous minimally invasive method for creating a venous valve |
KR20180099482A (ko) * | 2017-02-27 | 2018-09-05 | 고려대학교 산학협력단 | 하이드로겔 중합체를 이용한 탈세포화 조직의 제조방법 및 이로부터 제조된 탈세포화 조직 |
EP3638310A4 (en) * | 2017-06-12 | 2021-04-14 | The University Of North Carolina At Chapel Hill | PATCH GRAFT COMPOSITIONS FOR CELLULAR TRANSPLANTATION |
CN107550935A (zh) * | 2017-09-11 | 2018-01-09 | 上海亚睿生物科技有限公司 | 一种治疗关节疾病的生物凝胶剂及其应用 |
CL2017002357A1 (es) * | 2017-09-16 | 2018-04-20 | Cells For Cells S A | Método de obtención de una composición que contiene una población específica de células mesenquimales de cordón umbilical y sus usos |
US11285177B2 (en) | 2018-01-03 | 2022-03-29 | Globus Medical, Inc. | Allografts containing viable cells and methods thereof |
CN108144128B (zh) * | 2018-02-07 | 2021-11-05 | 陕西佰傲再生医学有限公司 | 一种多次交联乳房补片及其制备方法 |
CN108543116B (zh) * | 2018-05-02 | 2021-04-27 | 深圳市华异生物科技有限责任公司 | 海藻酸钠与明胶复合水凝胶3d胰岛支架及其制备方法 |
CN113166722A (zh) | 2018-10-03 | 2021-07-23 | 斯特姆生物系统有限公司 | 羊水细胞来源的细胞外基质及其用途 |
CN109793927A (zh) * | 2019-01-24 | 2019-05-24 | 中国人民解放军军事科学院军事医学研究院 | 基于细胞外衍生基质修饰的丝素蛋白多孔支架的制备方法 |
EP3927814A1 (en) | 2019-02-21 | 2021-12-29 | Stembiosys, Inc. | Methods for the maturation of cardiomyocytes on amniotic fluid cell-derived ecm, cellular constructs, and uses for cardiotoxicity and proarrhythmic screening of drug compounds |
CN110075357A (zh) * | 2019-04-02 | 2019-08-02 | 浙江大学 | 一种脂肪干细胞与纳米丝素复合的骨修复材料的制备方法 |
WO2020207426A1 (zh) * | 2019-04-10 | 2020-10-15 | 上海交通大学医学院附属上海儿童医学中心 | 一种体内植入性微孔囊袋及其使用方法和应用 |
US11298220B2 (en) | 2019-05-03 | 2022-04-12 | Lifecell Corporation | Breast treatment device |
CN110106148B (zh) * | 2019-05-16 | 2020-10-13 | 中国人民解放军军事科学院军事医学研究院 | 一种组织工程化神经组织及其构建方法 |
CN110409059A (zh) * | 2019-07-30 | 2019-11-05 | 北京化工大学常州先进材料研究院 | 甲基丙烯酸二甲氨基乙酯增强的丙烯酰化pgs纳米纤维膜的制备方法 |
CN112342187A (zh) * | 2019-08-06 | 2021-02-09 | 中晶生物技术股份有限公司 | 一种软骨细胞培养基及其制备方法 |
CN110904044B (zh) * | 2019-12-17 | 2022-07-19 | 陕西师范大学 | 一种肿瘤干细胞的三维培养方法 |
CN111407353A (zh) * | 2020-02-26 | 2020-07-14 | 邹洪 | 一种新型蚕丝蛋白材料制作的结扎钉夹 |
US11725112B2 (en) * | 2020-02-28 | 2023-08-15 | Lawrence Livermore National Security, Llc | Three-dimensional printed porous silicone matrix using leachable porogen |
RU2749801C1 (ru) * | 2020-03-06 | 2021-06-17 | Галина Мироновна Могильная | Способ восстановления утраченного объема дермы в эксперименте на крысах |
CN111690604A (zh) * | 2020-06-24 | 2020-09-22 | 杭州原生生物科技有限公司 | 一种msc体外扩增方法 |
KR102527152B1 (ko) * | 2021-02-15 | 2023-04-28 | 울산과학기술원 | 강유전성 생분해 고분자층을 포함하는 전자 피부 |
CN113456893B (zh) * | 2021-07-26 | 2022-04-26 | 温州医科大学附属眼视光医院 | 一种包被纤维蛋白原的蓝染羊膜基底膜的制备方法 |
CN115105637B (zh) * | 2022-07-28 | 2023-11-10 | 上海交通大学医学院附属第九人民医院 | 结膜下成纤维细胞脱细胞基质在结膜重建方面的应用 |
WO2024092220A2 (en) * | 2022-10-28 | 2024-05-02 | University Of Connecticut | Prosthetic device for tissue regeneration |
CN117582557B (zh) * | 2024-01-19 | 2024-03-19 | 四川恒普科技有限公司 | 脱矿骨纤维及其制备方法 |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2018228C (en) | 1989-06-05 | 1996-02-27 | Nancy L. Parenteau | Cell culture systems and media |
US5460962A (en) | 1994-01-04 | 1995-10-24 | Organogenesis Inc. | Peracetic acid sterilization of collagen or collagenous tissue |
JPH10500305A (ja) | 1994-05-11 | 1998-01-13 | オーガノジェネシス インコーポレイテッド | 細胞培養由来コラーゲン |
JP2000517188A (ja) * | 1996-08-30 | 2000-12-26 | ライフ テクノロジーズ,インコーポレイテッド | 無血清哺乳動物細胞培養培地およびその使用 |
US5993844A (en) * | 1997-05-08 | 1999-11-30 | Organogenesis, Inc. | Chemical treatment, without detergents or enzymes, of tissue to form an acellular, collagenous matrix |
US6291240B1 (en) * | 1998-01-29 | 2001-09-18 | Advanced Tissue Sciences, Inc. | Cells or tissues with increased protein factors and methods of making and using same |
CN1333818A (zh) | 1998-11-19 | 2002-01-30 | 奥加诺吉尼西斯公司 | 生物工程化的组织构建物、其制备方法及其应用 |
US6372494B1 (en) * | 1999-05-14 | 2002-04-16 | Advanced Tissue Sciences, Inc. | Methods of making conditioned cell culture medium compositions |
DK1226233T3 (da) * | 1999-08-05 | 2011-10-03 | Abt Holding Co | Multipotente voksne stamceller og fremgangsmåder til isolering heraf |
EP1425024A4 (en) * | 2001-07-16 | 2007-04-18 | Depuy Products Inc | SCAFFOLD OF POROUS EXTRACELLULAR MATRIX AND METHOD THEREOF |
WO2003038075A1 (fr) * | 2001-10-30 | 2003-05-08 | Renomedix Institute Inc. | Procede permettant d'induire une differenciation de cellules souches embroyonnaires mesodermiques, de cellules es ou de cellules immortalisees dans des cellules du systeme nerveux |
US7166464B2 (en) * | 2001-12-11 | 2007-01-23 | Cytograft Tissue Engineering, Inc. | Method of culturing cells to produce a tissue sheet |
ES2351386T3 (es) * | 2003-02-11 | 2011-02-03 | John E. Davies | Células progenitoras procedentes de la gelatina de wharton de cordón umbilical humano . |
ATE489454T1 (de) * | 2003-08-01 | 2010-12-15 | Two Cells Co Ltd | Scaffoldfreies, selbstorganisiertes, 3 dimensionales, synthetisches gewebe |
US20050288796A1 (en) * | 2004-06-23 | 2005-12-29 | Hani Awad | Native soft tissue matrix for therapeutic applications |
CA2585547A1 (en) * | 2004-10-29 | 2006-05-11 | Centocor, Inc. | Chemically defined media compositions |
US8728463B2 (en) * | 2005-03-11 | 2014-05-20 | Wake Forest University Health Science | Production of tissue engineered digits and limbs |
US8454678B2 (en) * | 2005-03-19 | 2013-06-04 | Cook Biotech Incorporated | Prosthetic implants including ECM composite material |
JP4745750B2 (ja) * | 2005-08-01 | 2011-08-10 | 株式会社ツーセル | 動物幹細胞培養用無血清培地 |
JP2007528229A (ja) * | 2005-08-26 | 2007-10-11 | ソウル ナショナル ユニバーシティ インダストリー ファウンデーション | 臍帯血から分離された多能性幹細胞及びこれを含有する虚血性壊死疾患治療用細胞治療剤 |
CA2618731C (en) * | 2005-08-26 | 2021-12-28 | Regents Of The University Of Minnesota | Decellularization and recellularization of organs and tissues |
AU2007223276B2 (en) * | 2006-03-03 | 2012-12-20 | Organogenesis, Inc. | Oral tissue regeneration and repair |
CN101412985B (zh) * | 2007-10-15 | 2012-06-13 | 华东理工大学 | 用于骨髓间充质干细胞体外培养和扩增的无血清培养基 |
CN100563728C (zh) * | 2007-10-19 | 2009-12-02 | 中国人民解放军第四军医大学 | 含有外周血干细胞的组织工程皮肤及其制备方法 |
US20110293666A1 (en) * | 2007-11-28 | 2011-12-01 | Xianyan Wang | Bioengineered Tissue Constructs and Methods for Production and Use |
MX2010005791A (es) * | 2007-11-28 | 2010-08-10 | Organogenesis Inc | Construcciones de tejido hechas mediante bio-ingenieria y metodos para produccion y uso. |
RU86455U1 (ru) * | 2008-04-22 | 2009-09-10 | ФГУ "Московский научно-исследовательский онкологический институт им. П.А. Герцена Федерального агентства по высокотехнологичной медицинской помощи" РФ | Биоинженерная конструкция |
WO2013090911A1 (en) * | 2011-12-16 | 2013-06-20 | Wisconsin Alumni Research Foundation | Method for supporting human pluri potent stem cell cultures comprising culturing the cells in a medium comprising thermostable fgf - 1 proteins |
-
2011
- 2011-01-14 CA CA2787050A patent/CA2787050A1/en not_active Abandoned
- 2011-01-14 BR BR112012017463A patent/BR112012017463A2/pt not_active IP Right Cessation
- 2011-01-14 EP EP20110701589 patent/EP2524034A1/en not_active Withdrawn
- 2011-01-14 CN CN201710761777.3A patent/CN107802890A/zh active Pending
- 2011-01-14 RU RU2012132705A patent/RU2645473C2/ru not_active IP Right Cessation
- 2011-01-14 CN CN2011800139964A patent/CN102892880A/zh active Pending
- 2011-01-14 US US13/007,250 patent/US20110293667A1/en not_active Abandoned
- 2011-01-14 WO PCT/US2011/021362 patent/WO2011088365A1/en active Application Filing
- 2011-01-14 JP JP2012549128A patent/JP2013517292A/ja active Pending
- 2011-01-14 AU AU2011205674A patent/AU2011205674A1/en not_active Abandoned
- 2011-01-14 SG SG2012051769A patent/SG182508A1/en unknown
- 2011-01-14 MX MX2012008215A patent/MX354068B/es active IP Right Grant
-
2012
- 2012-07-12 IL IL220903A patent/IL220903A0/en unknown
-
2016
- 2016-05-26 JP JP2016105464A patent/JP2016182126A/ja active Pending
-
2018
- 2018-05-09 JP JP2018090441A patent/JP2018117643A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
US20110293667A1 (en) | 2011-12-01 |
SG182508A1 (en) | 2012-08-30 |
JP2018117643A (ja) | 2018-08-02 |
JP2013517292A (ja) | 2013-05-16 |
WO2011088365A1 (en) | 2011-07-21 |
CA2787050A1 (en) | 2011-07-21 |
MX2012008215A (es) | 2012-10-15 |
JP2016182126A (ja) | 2016-10-20 |
EP2524034A1 (en) | 2012-11-21 |
IL220903A0 (en) | 2012-09-24 |
CN102892880A (zh) | 2013-01-23 |
CN107802890A (zh) | 2018-03-16 |
AU2011205674A1 (en) | 2012-08-09 |
RU2645473C2 (ru) | 2018-02-21 |
MX354068B (es) | 2018-02-09 |
RU2012132705A (ru) | 2014-02-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112012017463A2 (pt) | constructos de tecido de bioengenharia e métodos para sua produção e uso | |
BR112015017174A2 (pt) | preparação de enxertos de nervo de tecido manipulado com matriz extracelular modificada para reparo de lesão de nervo periférico | |
MX2010005791A (es) | Construcciones de tejido hechas mediante bio-ingenieria y metodos para produccion y uso. | |
BR112015023515A8 (pt) | construtos de tecido hepático tridimensionais vivos engenheirados, métodos para fabricá-los e uso destes para aumentar uma ou mais funções hepáticas em um ser humano | |
CL2014003225A1 (es) | Composición que comprende un agente de control biológico y un fungicida. | |
BR112015011933A2 (pt) | composições bacterianas sinérgicas e métodos de produção e uso das mesmas | |
BR112013006395A2 (pt) | moduladores do receptor de estrogênio e seus usos. | |
PE20150223A1 (es) | Anticuerpos antagonistas mejorados contra factor-8 de crecimiento y diferenciacion y usos de los mismos | |
BR112013028306A2 (pt) | plantas com características úteis e processos relacionados | |
BR112012030818A2 (pt) | "derivados de ácido c-3 betulínico modificado como inibidores da maturação do hiv" | |
BR112013027307A2 (pt) | método para tratar uma matriz de tecido; matriz de tecido acelular | |
MX2013008850A (es) | Composiciones y metodos para tratar enfermedades cardiovasculares. | |
BR112012019874A2 (pt) | "armações organometálicas derivadas a partir de metais carbenofilicos e método de produção das mesmas." | |
BR112012024963A2 (pt) | organossilicones | |
CO6440531A2 (es) | 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso | |
BR112012014904A2 (pt) | artigo abrasivo , artigo revestido e método de formar um artigo abrasivo | |
UY31277A1 (es) | Nuevos derivados de 6-triazolopiridacina -sulfanil benzotiazol y bencimidazol, su procedimiento de preparacion, su aplicacion como medicamentos, composiciones farmacéuticas y nueva utilizacion principalmente como inhibidores de met | |
BR112012020558A2 (pt) | moduladores do receptor de androgênio e seus usos | |
BRPI1011934A8 (pt) | Composição | |
CO6420355A2 (es) | Anticuerpos biespecíficos anti-erbb-3/anti-c-met | |
BR112012032008A2 (pt) | anticorpos s100a4 e usos terapêuticos do mesmo | |
BR112013025777A2 (pt) | imidazopiridazinas como inibidores da quinase akt | |
BR112016003339A2 (pt) | composição de enzima, e, processo de produção de um produto de fermentação a partir de material contendo amido | |
BR112013009083A2 (pt) | anticorpos humanos de oncostatin m e métodos de uso | |
CO6761392A2 (es) | Administración de proteínas a partir de microportadores de células madre |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 4A E 5A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |